Eisazadeh, Roya
Mirshahvalad, Seyed Ali
Schwieghofer-Zwink, Gregor
Hehenwarter, Lukas
Rendl, Gundula
Gampenrieder, Simon
Greil, Richard
Pirich, Christian
Beheshti, Mohsen http://orcid.org/0000-0003-3918-3812
Funding for this research was provided by:
Paracelsus Medical University
Article History
Received: 9 November 2023
Revised: 15 January 2024
Accepted: 6 February 2024
First Online: 15 February 2024
Declarations
:
: This retrospective study was performed in accordance with the principles of the 1964 Declaration of Helsinki and its later amendments or comparable standards and approved by the ethics committee of the province with the trial number of “1067/2023”.
: A signature of the written informed consent was obtained from all individuals in the clinical setting performing [<sup>68</sup> Ga]Ga-PSMA-11 PET/CT examinations.
: Mohsen Beheshti reports a relationship with Novartis Pharma GmbH that includes board membership and consulting or advisory.Christian Pirich reports a relationship with Novartis Pharma GmbH that includes board membership and consulting or advisory.